Retraction

A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells

Citations (47)

47
Total Citations
0
Post-Retraction
46
Pre-Retraction
1
Same Day
Retraction: A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells
Unknown Authors
PLoS ONE Open Access
Published: Feb 2025
Same day as retraction
A detailed review on the role of miRNAs in mitochondrial–nuclear cross talk during cancer progression
Amoolya Kandettu, Raviprasad Kuthethur, Sanjiban Chakrabarty
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Open Access
Published: Feb 2025
1 citation
23 days before retraction
MicroRNA-203a inhibits breast cancer progression through the PI3K/Akt and Wnt pathways
Maryam Entezari, Bahram M. Soltani, Majid Sadeghizadeh
Scientific Reports Open Access
Published: Feb 2024
5 citations
363 days before retraction
The Critical Function of microRNAs in Developing Resistance against 5- Fluorouracil in Cancer Cells
Farhad Sheikhnia, Hossein Maghsoudi, Maryam Majidinia
Mini-Reviews in Medicinal Chemistry
Published: Aug 2023
4 citations
545 days before retraction
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
Shivam Singh, Heena Saini, Ashok Kumar Sharma et al. (6 authors)
Frontiers in Oncology Open Access
Published: Jun 2023
17 citations
619 days before retraction
miRNAs as potential game-changers in bone diseases: Future medicinal and clinical uses
Ahmed S. Doghish, Mohammed S. Elballal, Ola Elazazy et al. (14 authors)
Pathology - Research and Practice
Published: Apr 2023
55 citations
690 days before retraction
FBXL2 promotes E47 protein instability to inhibit breast cancer stemness and paclitaxel resistance
Fengtian Li, Mengmeng Niu, Kewei Qin et al. (12 authors)
Oncogene
Published: Dec 2022
9 citations
815 days before retraction
Receptor-Mediated Targeting in Breast Cancer through Solid Lipid Nanoparticles and Its Mechanism
Zoya Malik, Rabea Parveen, Sageer Abass et al. (6 authors)
Current Drug Metabolism
Published: Apr 2022
11 citations
1043 days before retraction
The Role of Non-Coding RNAs in Breast Cancer Drug Resistance
Jinhai Tian, Shihai Liu, Chuan-yang Yu et al. (5 authors)
Frontiers in Oncology Open Access
Published: Sep 2021
18 citations
1260 days before retraction
Epigenetic Regulation of Breast Cancer Stem Cells Contributing to Carcinogenesis and Therapeutic Implications
Hsing‐Ju Wu, Pei‐Yi Chu
International Journal of Molecular Sciences Open Access
Published: Jul 2021
18 citations
1306 days before retraction
miR-33a-5p in small extracellular vesicles as non-invasive biomarker for oxaliplatin sensitivity in human colorectal cancer cells
Shota Tanaka, Mika Hosokawa, Takumi Miyamoto et al. (8 authors)
Biochemistry and Biophysics Reports Open Access
Published: Apr 2021
7 citations
1419 days before retraction
Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks
Arpan De, Dilshan Harshajith Beligala, Vishal P. Sharma et al. (6 authors)
Clinical & Experimental Metastasis
Published: Aug 2020
27 citations
1649 days before retraction
Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone Sarcomas
Camille Jacques, Robel Tesfaye, Mélanie Lavaud et al. (7 authors)
Cells Open Access
Published: Mar 2020
24 citations
1795 days before retraction
A Differential Role of miRNAs in Regulation of Breast Cancer Stem Cells
Shreetama Bandyopadhayaya, Chandi C. Mandal
Springer eBooks
Published: Jan 2020
2 citations
1881 days before retraction
MicroRNAs, a Promising Target for Breast Cancer Stem Cells
Plabon Kumar Das, Mst. Ayesha Siddika, Saharia Yeasmin Asha et al. (8 authors)
Molecular Diagnosis & Therapy
Published: Nov 2019
26 citations
1921 days before retraction
<i>Retracted</i>: Anticancer effects of miR‐200c in colorectal cancer through BMI1
Mitra Karimi Mazraehshah, Seyed Mohammad Tavangar, Massoud Saidijam et al. (7 authors)
Journal of Cellular Biochemistry
Published: Sep 2018
16 citations
2368 days before retraction
BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer
M. Janaki Ramaiah, S. Vaishnave
Gene
Published: Aug 2018
50 citations
2392 days before retraction
LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer
Liyun Luo, Hailin Tang, Ling Li et al. (17 authors)
Oncogene
Published: Jul 2018
138 citations
2419 days before retraction
MALAT1 promotes the colorectal cancer malignancy by increasing DCP1A expression and miR203 downregulation
Chuanqing Wu, Xiaojie Zhu, Kaixiong Tao et al. (8 authors)
Molecular Carcinogenesis
Published: Jul 2018
50 citations
2429 days before retraction
Suppressive and Hypermethylated MicroRNAs in the Pathogenesis of Breast Cancer
В. И. Логинов, Е. А. Филиппова, С. В. Куревлев et al. (6 authors)
Russian Journal of Genetics
Published: Jul 2018
3 citations
2430 days before retraction
Gene Silencing Strategies in Cancer Therapy: An Update for Drug Resistance
Sanaz Naghizadeh, Behzad Mansoori, Ali Mohammadi et al. (5 authors)
Current Medicinal Chemistry
Published: Apr 2018
16 citations
2518 days before retraction
The Amphibolous Role of miR-203 in Gastrointestinal and Urogenital Cancers
Lei Zhan, Bing Wei
International Journal of Animal Science and Technology
Published: Jan 2018
2610 days before retraction
The mechanism of BMI1 in regulating cancer stemness maintenance, metastasis, chemo- and radiation resistance
Xiaoshan Xu, Zhen Wang, Nan Liu et al. (7 authors)
Cancer translational medicine
Published: Jan 2018
1 citation
2611 days before retraction
MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells (Review)
Xuemei Fan, Wei Chen, Ziyi Fu et al. (6 authors)
Oncology Letters Open Access
Published: Sep 2017
14 citations
2733 days before retraction
Insights into the involvement of noncoding RNAs in 5-fluorouracil drug resistance
Jun Deng, Yi Wang, Jun Lei et al. (5 authors)
Tumor Biology Open Access
Published: Apr 2017
34 citations
2886 days before retraction
microRNAS in Therapy Resistance of Breast Cancer
Janine Jung, Vinona Wagner, Cindy Körner
EMJ Oncology Open Access
Published: Nov 2016
2 citations
3016 days before retraction
miR-203a is involved in HBx-induced inflammation by targeting Rap1a
Airong Wu, Huo Chen, Chunfang Xu et al. (9 authors)
Experimental Cell Research
Published: Oct 2016
21 citations
3047 days before retraction
Direct interaction between miR-203 and ZEB2 suppresses epithelial&amp;ndash;mesenchymal transition signaling and reduces lung adenocarcinoma chemoresistance
Xunhuang Duan, Zhaojian Fu, Lingyuan Gao et al. (8 authors)
Acta Biochimica et Biophysica Sinica Open Access
Published: Oct 2016
32 citations
3058 days before retraction
Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet’s disease
Burak Erer, Masaki Takeuchi, Duran Üstek et al. (11 authors)
Genes and Immunity Open Access
Published: Oct 2016
18 citations
3063 days before retraction
miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1
Nibedita Patel, Koteswara Rao Garikapati, M. Janaki Ramaiah et al. (6 authors)
Life Sciences
Published: Sep 2016
57 citations
3089 days before retraction
Regulation of Cell Proliferation and Migration by miR-203 via GAS41/miR-10b Axis in Human Glioblastoma Cells
Dhananjaya Pal, Debasmita Mukhopadhyay, M. Janaki Ramaiah et al. (6 authors)
PLoS ONE Open Access
Published: Jul 2016
24 citations
3133 days before retraction
Auraptene Attenuates Malignant Properties of Esophageal Stem-Like Cancer Cells
Saffiyeh Saboormaleki, Fatemeh Behnam Rassouli, Maryam Moghaddam Matin et al. (4 authors)
Technology in Cancer Research & Treatment Open Access
Published: May 2016
30 citations
3202 days before retraction
Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer
Shusuke Toden, Hanh-My T. Tran, Oscar Tovar-Camargo et al. (5 authors)
Oncotarget Open Access
Published: Feb 2016
160 citations
3290 days before retraction
Expression of stem cell‐regulating mi<scp>RNA</scp>s in oral cavity and oropharynx squamous cell carcinoma
Bárbara de Lima Brito, Sílvia Vanessa Lourenço, Aline Santos Damascena et al. (6 authors)
Journal of Oral Pathology and Medicine
Published: Feb 2016
24 citations
3309 days before retraction
BMI1: A Biomarker of Hematologic Malignancies
Anagh A. Sahasrabuddhe
Biomarkers in Cancer Open Access
Published: Jan 2016
46 citations
3342 days before retraction
MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin
Xin Zhang, Yanli Zhang, Xinfeng Liu et al. (10 authors)
PLoS ONE Open Access
Published: Nov 2015
56 citations
3381 days before retraction
Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling
Guanqun Ge, Can Zhou, Yu Ren et al. (10 authors)
Tumor Biology
Published: Nov 2015
40 citations
3398 days before retraction
Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1‐ABCG2 signaling
Jie Su, Shifei Wu, Wei Tang et al. (6 authors)
Molecular Carcinogenesis
Published: Oct 2015
36 citations
3406 days before retraction
Effect of shRNA-Mediated Gene Silencing of Bmi-1 Expression on Chemosensitivity of CD44+ Nasopharyngeal Carcinoma Cancer Stem-Like Cells
Xin-Hua Xu, Yang Liu, Daojun Li et al. (10 authors)
Technology in Cancer Research & Treatment Open Access
Published: Aug 2015
7 citations
3475 days before retraction
P53-dependent miRNAs mediate nitric oxide-induced apoptosis in colonic carcinogenesis
Weiwei Li, Wenxiao Han, Yiming Ma et al. (7 authors)
Free Radical Biology and Medicine
Published: Apr 2015
26 citations
3593 days before retraction
Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential
Jelena Knežević, Adam D. Pfefferle, Ivana Petrović et al. (6 authors)
Oncogene Open Access
Published: Mar 2015
106 citations
3640 days before retraction
MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer
Jun Xiang, Cuidong Bian, Hao Wang et al. (5 authors)
Journal of Experimental & Clinical Cancer Research Open Access
Published: Jan 2015
68 citations
3678 days before retraction
Regulation of miRNAs by Agents Targeting the Tumor Stem Cell Markers DCLK1, MSI1, LGR5, and BMI1
Sripathi M. Sureban, Dongfeng Qu, Courtney W. Houchen
Current Pharmacology Reports Open Access
Published: Jan 2015
13 citations
3685 days before retraction
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
Gloria Bertoli, Claudia Cava, Isabella Castiglioni
Theranostics Open Access
Published: Jan 2015
769 citations
3707 days before retraction
miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer
Tao Li, Feng Gao, Xi-Peng Zhang
Oncology Reports Open Access
Published: Dec 2014
73 citations
3735 days before retraction
Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes
Patricia Baxter, Lin Qi, Hua Mao et al. (21 authors)
Acta Neuropathologica Communications Open Access
Published: Dec 2014
29 citations
3738 days before retraction
The role of microRNAs in human breast cancer progression
WenCheng Zhang, Jinbo Liu, Guangshun Wang
Tumor Biology
Published: Jun 2014
64 citations
3904 days before retraction